{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "22138654",
  "DateCompleted": {
    "Year": "2012",
    "Month": "11",
    "Day": "29"
  },
  "DateRevised": {
    "Year": "2013",
    "Month": "11",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2011",
        "Month": "12",
        "Day": "03"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.jmii.2011.09.017"
    ],
    "Journal": {
      "ISSN": "1995-9133",
      "JournalIssue": {
        "Volume": "45",
        "Issue": "4",
        "PubDate": {
          "Year": "2012",
          "Month": "Aug"
        }
      },
      "Title": "Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi",
      "ISOAbbreviation": "J Microbiol Immunol Infect"
    },
    "ArticleTitle": "Epididymo-orchitis: an unusual manifestation of salmonellosis.",
    "Pagination": {
      "StartPage": "318",
      "EndPage": "320",
      "MedlinePgn": "318-20"
    },
    "Abstract": {
      "AbstractText": [
        "Salmonellosis continues to be a major public health problem, especially in developing countries. The formation of focal abscesses may occur following either hematogenous or lymphatic spread. There are large number of serious and life-threatening clinical manifestations of Salmonella spp., ranging from osteomyelitis to infective endocarditis and meningitis. However, even though Salmonella epidydimo-orchitis is a relatively rare clinical manifestion, it can present, most often in male babies and adolescent boys, following contact with nontyphoidal Salmonella. Here, we report a case of epididymo-orchitis due to Salmonella Paratyphi A that presented in an otherwise healthy 63-year-old man in order to highlight this organism's unusual clinical presentation. In countries such as India, where Salmonella infections are endemic, a high index of suspicion should be always be maintained and the possibility of a Salmonella infection at an aberrant site where it is hardly expected should not be ruled out."
      ],
      "CopyrightInformation": "Copyright \u00a9 2012. Published by Elsevier B.V."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology, Government Medical College Hospital, Chandigarh, India. drneha_bansal@yahoo.com"
          }
        ],
        "LastName": "Bansal",
        "ForeName": "Neha",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kaistha",
        "ForeName": "Neelam",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Chander",
        "ForeName": "Jagdish",
        "Initials": "J"
      }
    ],
    "PublicationTypeList": [
      "Case Reports",
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "J Microbiol Immunol Infect",
    "NlmUniqueID": "100956211",
    "ISSNLinking": "1684-1182"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "5E8K9I0O4U",
      "NameOfSubstance": "Ciprofloxacin"
    },
    {
      "RegistryNumber": "75J73V1629",
      "NameOfSubstance": "Ceftriaxone"
    },
    {
      "RegistryNumber": "A4P49JAZ9H",
      "NameOfSubstance": "Ofloxacin"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "microbiology",
        "pathology"
      ],
      "DescriptorName": "Abscess"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Administration, Intravenous"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Administration, Oral"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Ceftriaxone"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Ciprofloxacin"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Developing Countries"
    },
    {
      "QualifierName": [
        "microbiology",
        "pathology"
      ],
      "DescriptorName": "Epididymitis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "India"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Ofloxacin"
    },
    {
      "QualifierName": [
        "microbiology",
        "pathology"
      ],
      "DescriptorName": "Orchitis"
    },
    {
      "QualifierName": [
        "microbiology",
        "pathology"
      ],
      "DescriptorName": "Salmonella Infections"
    },
    {
      "QualifierName": [
        "isolation & purification",
        "pathogenicity"
      ],
      "DescriptorName": "Salmonella paratyphi A"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    }
  ]
}